The basis for treatment in multiple sclerosis

Acta Neurologica Scandinavica. Supplementum
A Compston

Abstract

Contemporary licensed treatments for multiple sclerosis fail to provide a solution for the disease because their effects are limited to a modest reduction in the frequency of new episodes. They do not reduce disability or materially influence the progressive phase of the disease. A contemporary strategy for management requires a more detailed analysis of the separate contributions to the clinical features and overall course made by inflammation, axonal injury, compensatory mechanisms, and remyelination. From this formulation emerges the need either for early and fully effective suppression of the inflammatory response, limiting the damage to all components of the axon-glial unit; or the development of strategies for axonal and myelin repair that solve the issues of controlled differentiation, delivery and timing of these cell and growth factor-based interventions.

References

Sep 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·J D EnglandT E Finger
Jan 29, 1998·The New England Journal of Medicine·B D TrappL Bö
Aug 26, 1998·Proceedings of the National Academy of Sciences of the United States of America·B CannellaC S Raine
Nov 18, 2000·The New England Journal of Medicine·C ConfavreuxP Adeleine
Apr 20, 2001·Annals of Neurology·K J SmithM Davies
Feb 15, 2002·Brain : a Journal of Neurology·Guus Wolswijk
Apr 18, 2002·Journal of Neuroimmunology·R S NicholasD A Compston
Jun 4, 2002·Nature Medicine·Helmut ButzkuevenTrevor J Kilpatrick
Jan 23, 2003·Brain : a Journal of Neurology·M FilippiA Falini
Mar 30, 2004·Annals of Neurology·Michael H Barnett, John W Prineas
Jul 27, 2005·Journal of Neurology·Alasdair J ColesD Alastair Compston
Oct 19, 2005·Brain : a Journal of Neurology·Alexandra KutzelniggHans Lassmann
Nov 18, 2005·Journal of Neuroimmunology·Maciej JurynczykKrzysztof Selmaj
Jan 18, 2006·Brain : a Journal of Neurology·Christian Confavreux, Sandra Vukusic

❮ Previous
Next ❯

Citations

Sep 13, 2011·Multiple Sclerosis : Clinical and Laboratory Research·M Mateo Paz SoldánMoses Rodriguez
Apr 12, 2016·Multiple Sclerosis and Related Disorders·Douglas S GoodinEmmanuelle Waubant
Aug 14, 2012·Expert Review of Clinical Immunology·Carmen Tur, Xavier Montalban
Apr 13, 2010·Autoimmunity·Anthony SlavinMaryanne L Brown
Jan 23, 2013·Molecular Immunology·Xianzhen HuScott R Barnum
Jul 6, 2014·Health Expectations : an International Journal of Public Participation in Health Care and Health Policy·Abigail M MethleySudeh Cheraghi-Sohi
Sep 20, 2012·Revue neurologique·S Vukusic
Jun 30, 2012·Medicina clínica·Carmen TurCristina Aguilera
Dec 12, 2012·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·A GiordanoUNKNOWN POSMOS study
Mar 29, 2011·Neurologic Clinics·Gregory F Wu, Enrique Alvarez
Dec 15, 2010·Molecular Immunology·Kerstin BererGurumoorthy Krishnamoorthy
Dec 3, 2010·Revue neurologique·B BourreN Collongues
Jun 29, 2010·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Wei QiuAllan G Kermode
Nov 26, 2009·Autoimmunity Reviews·Ron Milo, Esther Kahana
Jan 26, 2007·Annals of Neurology·Tai Wai YeoStephen Sawcer
Feb 12, 2009·Statistics in Medicine·Brian C Healy, David Engler
Apr 11, 2007·Acta Neurologica Scandinavica. Supplementum·T Holmøy
Jan 12, 2012·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·A GiordanoUNKNOWN POSMOS study
Oct 13, 2009·Internal Medicine Journal·C ShawH Butzkueven
Feb 27, 2010·Annals of Neurology·Stephen SawcerFrank Dudbridge
Apr 14, 2016·Experimental Neurology·Ian D Duncan, Abigail B Radcliff
Jan 21, 2015·Journal of Neurology, Neurosurgery, and Psychiatry·Marzena J Fabis PedriniAllan G Kermode
Feb 11, 2015·Journal of Neuroradiology. Journal De Neuroradiologie·F CottonUNKNOWN Imaging Working Group of the Observatoire Français de la Sclérose en Plaques
Oct 4, 2006·Neuron·Stephen L Hauser, Jorge R Oksenberg
May 24, 2014·Lancet Neurology·Stephen SawcerMaria Ban
Jan 18, 2014·Multiple Sclerosis : Clinical and Laboratory Research·A SolariUNKNOWN SIMS-Trial, SIMS-Practice and Agorà studies
Jun 22, 2010·Multiple Sclerosis : Clinical and Laboratory Research·Eric M ChengBarbara G Vickrey
May 10, 2013·Multiple Sclerosis : Clinical and Laboratory Research·Carmen Tur, Xavier Montalban
Apr 18, 2014·Multiple Sclerosis : Clinical and Laboratory Research·A K KemppinenS Sawcer
Jul 26, 2008·Multiple Sclerosis : Clinical and Laboratory Research·J SmoldersR Hupperts
Oct 1, 2013·Nature Genetics·UNKNOWN International Multiple Sclerosis Genetics Consortium (IMSGC)Jacob L McCauley
Mar 28, 2008·Current Neurology and Neuroscience Reports·David M Dawson
Jun 11, 2011·Journal of Neurology·David PalingDavid Miller

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Related Papers

Current Opinion in Neurology
Orhun Kantarci, Dean Wingerchuk
Neurology
Ludwig KapposNorth American (NA-SPMS) Interferon beta-1b in Secondary Progressive Multiple Sclerosis Trial Steering Committee and Indepen
Current Opinion in Neurology
X Montalban
Neurological Research
Gregory P OwensMark P Burgoon
© 2022 Meta ULC. All rights reserved